Statin-carboxyalkylether combinations

Details Statin-carboxyalkylether combinations Statin-carboxyalkylether combinations

C - Chemistry, Metallurgy

07

F

C07F 3/04 (2006.01) A61K 31/19 (2006.01) A61K 31/22 (2006.01) A61K 31/35 (2006.01) A61K 31/365 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/44 (2006.01) A61P 3/06 (2006.01)

Patent

CA 2304612

The invention is a pharmaceutical composition comprising a carboxyalkylether which lowers triglycerides and elevated HDL, and a statin which inhibits HMG- CoA reductase, thereby reducing LDL, said composition being useful for treating vascular diseases.

L'invention est une composition pharmaceutique renfermant un carboxyalkylether abaissant les triglycérides et les polyprotéines de haute densité de niveau élevé, ainsi qu'une statine inhibant la HMG-CoA réductase, réduisant ainsi les lipoprotéines de basse densité, ladite composition étant utile pour traiter des maladies vasculaires.

Affiliated with

Also associated with

Rating

Statin-carboxyalkylether combinations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Statin-carboxyalkylether combinations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Statin-carboxyalkylether combinations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1588484